OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 13, Issue 4, Pages 224-236
Publisher
Informa UK Limited
Online
2012-02-22
DOI
10.4161/cbt.13.4.18877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COX-2 as a target for cancer chemotherapy
- (2014) Nilanjan Ghosh et al. Pharmacological Reports
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting
- (2011) Min Ni et al. BIOCHEMICAL JOURNAL
- A review of the mammalian unfolded protein response
- (2011) Anirikh Chakrabarti et al. BIOTECHNOLOGY AND BIOENGINEERING
- Biology of Cox-2: An Application in Cancer Therapeutics
- (2011) Zakir Khan et al. CURRENT DRUG TARGETS
- The Cell Biology of the Unfolded Protein Response
- (2011) J. Alan Diehl et al. GASTROENTEROLOGY
- Beyond Standard Adjuvant Therapy for Colon Cancer: Role of Nonstandard Interventions
- (2011) Jeffrey A. Meyerhardt SEMINARS IN ONCOLOGY
- Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis
- (2010) Tomoaki Ishihara et al. BIOCHEMICAL PHARMACOLOGY
- Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy
- (2010) Claudia Cerella et al. BIOCHEMICAL PHARMACOLOGY
- The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?
- (2010) Martin McLaughlin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Progress in COX-2 Inhibitors: A Journey So Far
- (2010) Asit Chakraborti et al. CURRENT MEDICINAL CHEMISTRY
- Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Sorafenib Plus Valproic Acid for Infant Spinal Glioblastoma
- (2010) Christopher Alan Rokes et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
- (2010) E Bobrovnikova-Marjon et al. ONCOGENE
- ATF4, an ER Stress and Hypoxia-Inducible Transcription Factor and its Potential Role in Hypoxia Tolerance and Tumorigenesis
- (2009) Jiangbin Ye et al. CURRENT MOLECULAR MEDICINE
- OSU-03012 Stimulates PKR-Like Endoplasmic Reticulum-Dependent Increases in 70-kDa Heat Shock Protein Expression, Attenuating Its Lethal Actions in Transformed Cells
- (2008) M. A. Park et al. MOLECULAR PHARMACOLOGY
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started